Autoimmune Diseases  >>  Kenketsu Glovenin-I (normal human immunoglobulin IV)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
NPB-01, NCT00809822: Clinical Trial of in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.

Completed
2
20
Japan
NPB-01, Placebo
Nihon Pharmaceutical Co., Ltd
Bullous Pemphigoid
10/10
10/10
NCT01845584: Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

Completed
2
7
Japan
NPB-01, Intravenous immunoglobulin
Nihon Pharmaceutical Co., Ltd
Neuromyelitis Optica Spectrum Disorder
08/15
08/15

Download Options